(Q77668001)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

phase III clinical trial

1 reference

0 references

U Jungnelius

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

U Ringborg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Aamdal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J Mattsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

U Stierner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Ingvar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Malmström

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Andersson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Karlsson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K Willman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Wist

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Bjelkengren

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Westberg

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1368-1374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Update results of vindesine as a single agent in the therapy of advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Vindesine as a single agent in the treatment of advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Chemotherapy for advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900068-9

7 January 2021

10.1016/S0959-8049(98)00068-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849419%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference